Communication Conundrum: Is Early Drug Safety Disclosure Better?

FDA's inaugural quarterly web posting of early safety signals with marketed drugs and biologics has left investors bewildered over how to interpret the listings. But the presence of rigorous risk management programs may be a comforting factor for Wall Street and Big Pharma.